Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11225508 Mouse-adapted SARS-CoV-2 viruses and methods of use thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ralph Baric0

Sarah Rebecca Leist0

Kenneth Harold Dinnon, III0

Date of Patent

January 18, 2022

0

Patent Application Number

171736170

Date Filed

February 11, 2021

0

Patent Citations Received

US Patent 11492379 SARS-CoV-2 viruses and methods of use thereof

US Patent 11903953 Remdesivir treatment methods

0

US Patent 11926645 Compounds and methods for treatment of viral infections

0

US Patent 11939347 1′-cyano nucleoside analogs and uses thereof

0

US Patent 12012431 Methods of preparing 1′-cyano nucleosides

0

Patent Primary Examiner

Shanon A. Foley

0

Patent abstract

This invention relates to SARS-CoV-2 viruses adapted with nanoluciferase reporter molecules and mouse-adapted SARS-CoV-2 viruses, compositions including the same and methods of use thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11225508 Mouse-adapted SARS-CoV-2 viruses and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool